$41.15
3.298.69%
At close: -
$41.00
-0.15-0.36%
After Hours: 5:36 PM EDT
15 minutes delayed
Comments
Loading...
Structure Therapeutics (GPCR) Forecast
NewsEarningsStructure Therapeutics (GPCR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestStructure Therapeutics (NASDAQ:GPCR) Stock Quotes, Forecast and News Summary
Structure Therapeutics Stock (NASDAQ: GPCR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Structure Therapeutics (GPCR) stock?
You can purchase shares of Structure Therapeutics (NASDAQ:GPCR) through any online brokerage.
Who are Structure Therapeutics (GPCR) competitors?
Other companies in Structure Therapeutics’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).
What is the forecast, or price target, for Structure Therapeutics (GPCR) stock?
Structure Therapeutics has a consensus price target of $77.33.
What is the current price for Structure Therapeutics (GPCR)?
The stock price for Structure Therapeutics (NASDAQ: GPCR) is $41 last updated October 31, 2024 at 5:36 PM EDT.
Does Structure Therapeutics (GPCR) pay a dividend?
There are no upcoming dividends for Structure Therapeutics.
When is Structure Therapeutics (NASDAQ:GPCR) reporting earnings?
Structure Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Structure Therapeutics (GPCR) going to split?
There is no upcoming split for Structure Therapeutics.
What sector and industry does Structure Therapeutics (GPCR) operate in?
Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.